<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nipah, Hendra, and other henipaviruses</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nipah, Hendra, and other henipaviruses</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nipah, Hendra, and other henipaviruses</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adeeba Kamarulzaman, MBBS, FRACP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Khean Jin Goh, MBBS, FRCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer Mitty, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Nipah and Hendra viruses are two related zoonotic pathogens that have emerged in the Asia-Pacific region. Both are RNA viruses belonging to the <em>Paramyxoviridae</em> family and grouped under the genus <em>Henipavirus</em>, since they share antigenic, serological, and ultrastructural characteristics and differ from other paramyxoviruses [<a href="#rid1">1-4</a>]. Another virus in the genus is the non-pathogenic Cedar virus [<a href="#rid5">5</a>]. A phylogenetically distinct henipavirus, named Langya henipavirus (LayV), was identified in 2019. </p><p>Nipah virus first caused an outbreak in pigs and humans in Malaysia and Singapore between 1998 and 1999 and has caused recurrent human outbreaks in Bangladesh and West Bengal, India since 2001 and in Kerala, India since 2018 [<a href="#rid6">6-14</a>]. Outbreaks have also occurred in the Philippines in 2014 and Kerala, India in 2018 [<a href="#rid14">14,15</a>]. Hendra virus infections affecting horses and humans have occurred in Australia since 1994 [<a href="#rid16">16-19</a>].</p><p class="headingAnchor" id="H2"><span class="h1">NIPAH VIRUS</span></p><p class="headingAnchor" id="H833964630"><span class="h2">Epidemiology of Nipah virus infection</span><span class="headingEndMark"> — </span>Nipah virus was initially discovered when it caused an outbreak of viral encephalitis among pig farmers in Malaysia. The virus was named after a village in Malaysia, where the infected patient lived. Since then, there have been several outbreaks of acute Nipah encephalitis in various districts in Bangladesh, in the neighboring district of Siliguri in India, and in the Southern Philippines [<a href="#rid13">13,15,20</a>]. In May 2018, an outbreak was reported in India's Kerala state [<a href="#rid14">14,21</a>].</p><p>The outbreak in Malaysia was initially thought to be Japanese encephalitis (JE), which is endemic in Asia. However, certain features were not consistent with this diagnosis: the occurrence of encephalitis among adults rather than children, the clustering of cases in the same household, and a history of illness in pigs belonging to the affected farmers [<a href="#rid7">7,9</a>]. Furthermore, a high number of patients had been vaccinated against JE [<a href="#rid7">7,9</a>]. (See  <a class="medical medical_review" href="/d/html/1293.html" rel="external">"Arthropod-borne encephalitides", section on 'Japanese encephalitis virus'</a>.)</p><p class="headingAnchor" id="H4"><span class="h3">Animal reservoirs</span><span class="headingEndMark"> — </span>The primary animal reservoirs of henipaviruses are bats of the genus <em>Pteropus</em> [<a href="#rid22">22-27</a>]. Antibodies against Nipah antigens were found in bats from Malaysia and Bangladesh, and the virus was isolated from urine of bats of the species <em>Pteropus hypomelanus</em> roosting in the East Coast of Malaysia [<a href="#rid10">10,22,26</a>]. In Bangladesh and India, the virus was found in <em>Pteropus medius</em> [<a href="#rid28">28</a>]. Serologic evidence of Nipah virus infection has been found in 23 species of bats from 10 genera in regions such as Yunan and Hainan Island in China, Cambodia, Thailand, India, Madagascar, and Ghana in West Africa [<a href="#rid27">27</a>]. Serologic evidence of henipa-like virus infection has also been found in bats in Brazil, suggesting potential host reservoirs in the western hemisphere [<a href="#rid29">29</a>].</p><p>Other animals can be intermediate hosts for the virus. As an example, in the Malaysian outbreak, these were pigs [<a href="#rid7">7,9</a>]. Unlike in JE, Nipah-infected pigs had clinical disease manifested by neurologic and respiratory symptoms [<a href="#rid30">30,31</a>]. The mode of transmission between pigs was probably through direct contact with infected fluids such as urine, saliva, pharyngeal and bronchial secretions. Domestic animals such as cats and dogs were also shown to have a positive serology for Nipah virus [<a href="#rid9">9</a>]. In the Philippines outbreak, horses were thought to be the intermediate hosts [<a href="#rid15">15</a>]. (See <a class="local">'Individual outbreaks'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h3">Transmission to humans</span></p><p class="headingAnchor" id="H3328081352"><span class="h4">Modes of transmission</span><span class="headingEndMark"> — </span>Human infection results from spillover transmission from bats or through human-to-human transmission. Measures to prevent transmission are discussed below. (See <a class="local">'Treatment and prevention of Nipah virus infection'</a> below.)</p><p>Spillover transmission from bats can occur via two mechanisms, either through direct bat-to-human transmission (eg, contact with bats or their secretions, consumption of raw date palm sap [<em>tari</em>] contaminated by bat saliva) or through indirect transmission from bats through an intermediate animal host (see <a class="local">'Animal reservoirs'</a> above). The risk of spillover transmissions appears to be related to environmental factors (eg, transmission is more likely to occur in cooler years) [<a href="#rid32">32</a>].</p><p>Human-to-human transmission appears to be impacted by the strain of virus and, as a result, the severity of disease manifestations [<a href="#rid33">33,34</a>]. As an example, the increased rate of human-to-human transmission demonstrated in Bangladesh may have occurred, in part, due to the increased severity of respiratory infection that was seen in those outbreaks [<a href="#rid33">33,35,36</a>]. In a study that evaluated 248 cases of Nipah virus infection in Bangladesh between 2001 and 2014, one-third were suspected to have acquired the infection via person-to-person transmission [<a href="#rid36">36</a>]. Twenty-two patients (9 percent) transmitted Nipah virus, and those who had difficulty breathing infected more contacts than those who did not (relative infectivity 23, 95% CI 4.1-130). Patients who were ≥45 years of age were also more likely to transmit infection. Among contacts, the risk of transmission increased with duration of exposure (adjusted odds ratio [AOR] for exposure &gt;48 versus ≤1 hour, 13; 95% CI 2.6-62) and exposure to body fluids (AOR 4.3; 95% CI 1.6-11). A more detailed discussion of the individual outbreaks is found below. (See <a class="local">'Individual outbreaks'</a> below.)</p><p class="headingAnchor" id="H3685532400"><span class="h4">Individual outbreaks</span><span class="headingEndMark"> — </span>Several outbreaks of Nipah virus infection illustrate how infection occurs both via animal and person-to-person transmission. (See <a class="local">'Modes of transmission'</a> above.)</p><p>In the 1998 to 1999 Malaysian outbreak, human infection occurred through contact with respiratory secretions and urine from an intermediate animal host, infected pigs. Case-control studies showed that Nipah-infected persons were more likely than controls to have had direct contact with pigs [<a href="#rid37">37,38</a>]. Other affected patients were those who had occupational contact, including abattoir workers and pork sellers [<a href="#rid37">37-40</a>]. In a study of military personnel involved in pig culling during the outbreak, 6 of the 1412 personnel (0.4 percent) studied had detectable antibody against Nipah virus [<a href="#rid40">40</a>]. All six had IgM antibodies and one person also had IgG antibodies. Two of the six had clinical encephalitis. There was also evidence that Nipah virus may have been transmitted from person to person. As an example, a nurse in the Malaysian outbreak who had cared for Nipah virus-infected patients was found to be seropositive and have MRI findings typical of Nipah encephalitis, despite the fact that she had no exposure to infected animals [<a href="#rid41">41</a>].</p><p>In Bangladesh and India, Nipah virus infection resulted from bat-to-human transmission and, subsequently, human-to-human transmission. After an initial report of Nipah virus infection in 2001, recurrent outbreaks occurred almost annually [<a href="#rid42">42,43</a>]. Unlike the Malaysian outbreaks, no clusters of ill animals were reported, and a case-control study found that there was no increased risk of Nipah virus infection among individuals who had contact with a potential intermediate host (such as a pig) [<a href="#rid10">10,12,44</a>]. It was subsequently found that Nipah infection resulted from direct contact with bats or their secretions [<a href="#rid44">44</a>] or consumption of raw date palm sap (<em>tari</em>) contaminated by bat saliva [<a href="#rid45">45</a>], and human-to-human transmission [<a href="#rid46">46,47</a>]. In February of 2023, 10 of the 11 cases that occurred during an outbreak in Bangladesh were linked to date palm sap [<a href="#rid48">48</a>]. </p><p>Human-to-human transmission was also important in the 2004 outbreak in Bangladesh, in which 33 of 36 reported cases had a history of close contact with another infected patient prior to the onset of illness [<a href="#rid46">46</a>]. Among patients with Nipah virus infection secondary to exposure from an infected patient, the median incubation period was nine days (range, 6 to 11 days) [<a href="#rid20">20</a>]. </p><p>In the 2014 Philippine outbreak, there was evidence of horse-to-human and human-to-human transmission. Ten of 17 patients (59 percent) had either been involved in slaughtering horses or consuming infected horse meat, while most of the others, including two healthcare workers, helped care for patients [<a href="#rid15">15</a>].</p><p>In an outbreak that occurred in India's Kerala state from May to June 2018, 23 patients were infected [<a href="#rid14">14</a>]. The index case was infected in the community (presumably via a bat), and the remaining cases resulted from person-to-person nosocomial transmission, which occurred in the three different hospitals. This outbreak was subsequently followed by individual sporadic cases in 2019 and 2021 [<a href="#rid49">49,50</a>].</p><p class="headingAnchor" id="H594441704"><span class="h2">Pathology</span><span class="headingEndMark"> — </span>In patients with Nipah virus encephalitis, the main pathology appears to be widespread ischemia and infarction caused by vasculitis-induced thrombosis, although direct neuronal invasion may also play a major role. Findings in the brains of patients with Nipah encephalitis have included necrotizing vasculitis and syncytial formation [<a href="#rid19">19,51</a>]. Eosinophilic cytoplasmic and nuclear viral inclusions were detected in many neurons adjacent to vasculitic vessels, a finding which may be present in infections caused by other paramyxoviruses.</p><p>In relapsed Nipah virus encephalitis, the pathology was confined to the central nervous system with extensive and confluent parenchymal necrosis, edema, and inflammation, but without vasculitis, endothelial syncytia, and thrombosis [<a href="#rid51">51,52</a>]. The presence of viral inclusions supported recurrent infection rather than a post-infectious encephalitis [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Clinical features of Nipah virus infection</span></p><p class="headingAnchor" id="H1112394013"><span class="h3">Signs and symptoms</span><span class="headingEndMark"> — </span>Nipah virus primarily causes an encephalitic and/or respiratory syndrome with a high mortality rate. The mortality rate was approximately 30 to 40 percent in Malaysia [<a href="#rid9">9</a>] and greater than 70 percent in Bangladesh [<a href="#rid20">20</a>]. During the outbreak in Kerala, India in 2018, 23 cases were identified, and only two patients survived (case fatality rate of 91 percent) [<a href="#rid14">14</a>]. However, a few patients may remain asymptomatic [<a href="#rid37">37</a>]. </p><p>The incubation period ranges from 7 to 40 days. The initial presentation is nonspecific, characterized by the sudden onset of fever, headache, myalgia, nausea and vomiting. Meningismus is seen in approximately one-third of patients, but marked nuchal rigidity and photophobia are uncommon. Respiratory symptoms including cough and dyspnea and abnormal chest radiographs were also seen in patients in the Kerala and Bangladesh outbreaks [<a href="#rid10">10-12,14,21,53</a>]. In Kerala, myocardial involvement (as evidenced by electrocardiogram changes), left ventricular hypokinesia, and elevated troponin I levels were also reported [<a href="#rid21">21</a>]. </p><p>In approximately 60 percent of patients, the disease rapidly progresses, with deterioration in consciousness leading to coma within five to seven days. Generalized seizures occur in approximately 20 percent of patients. Other neurologic findings associated with Nipah encephalitis include: segmental myoclonus (involving predominantly the diaphragm, upper limb and neck musculature), cerebellar dysfunction, tremors, and areflexia. Brainstem involvement, characterized by pinpoint, unreactive pupils, abnormal Doll's eye reflex, tachycardia and hypertension, occurs in the more severe cases and portends a poorer prognosis [<a href="#rid9">9</a>]. </p><p>Some patients had relapsing encephalitis presenting as recurrent episodes of neurological dysfunction. In addition, a few patients who were initially asymptomatic, or who had mild non-encephalitic illness initially, developed late onset neurological disease [<a href="#rid52">52</a>]. These patients presented with fever, headache, seizures and focal neurological signs. Mortality was 18 percent. MRI scans showed large patchy, confluent lesions that differed from the initial findings [<a href="#rid52">52,54</a>]. There was some similarity to a fatal case of Hendra viral encephalitis (see below) [<a href="#rid18">18</a>].</p><p>Long-term follow-up of survivors showed that persistent fatigue and daytime somnolence were common disabling symptoms [<a href="#rid55">55,56</a>]. Functional neurologic impairment was also common.</p><p class="headingAnchor" id="H7"><span class="h3">Laboratory findings</span><span class="headingEndMark"> — </span>The laboratory abnormalities in Nipah encephalitis are also nonspecific. Leukocyte counts are usually normal but moderate thrombocytopenia can occur. The liver transaminases were elevated in the mild-to-moderate range, but clinical jaundice was not a feature of the illness.</p><p>Abnormalities of the cerebrospinal fluid (CSF) were observed in the majority of cases. Most had an increased white blood cell count (range 10 to 800 cells/mm3), with lymphocyte predominance, and an elevated protein concentration (range 50 to 250 mg/dL). The CSF glucose concentration was normal, and red blood cells were not usually present. These findings are in keeping with the CSF abnormalities seen in most other viral encephalitides. (See  <a class="medical medical_review" href="/d/html/1284.html" rel="external">"Viral encephalitis in adults"</a>.)</p><p class="headingAnchor" id="H8"><span class="h3">Neuroimaging</span><span class="headingEndMark"> — </span>Magnetic resonance imaging (MRI) is a useful tool in the diagnosis of Nipah encephalitis [<a href="#rid54">54,57</a>] although it does not distinguish this form of encephalitis from other viral encephalitides. The characteristic MRI abnormalities are multiple, small (less than 5 mm), asymmetric focal lesions in the subcortical and deep white matter without surrounding edema. These lesions most probably represent areas of micro-infarction that have also been observed on histopathology. There is no correlation between MRI findings and focal neurological signs.</p><p class="headingAnchor" id="H9"><span class="h3">Electroencephalogram</span><span class="headingEndMark"> — </span>The electroencephalogram (EEG) shows continuous diffuse slow waves with or without periodic bitemporal independent sharp wave discharges.</p><p class="headingAnchor" id="H10"><span class="h2">Diagnosis of Nipah virus infection</span><span class="headingEndMark"> — </span>A definitive diagnosis of Nipah virus infection involves demonstrating the presence of virus in body fluids (eg, throat and nasal swabs, tissue samples, urine, blood and cerebrospinal fluid). However, virus isolation is not routinely done since Nipah virus is classified as a biosafety level 4 agent. Thus, other methods, such as polymerase chain reaction (PCR) or serology are more commonly employed.</p><p>With regards to serologic testing, the diagnosis of Nipah virus infection can be established by enzyme-linked immunoassay (ELISA). An IgM capture ELISA and an indirect IgG ELISA have high specificity for the diagnosis [<a href="#rid58">58</a>]. Typically, the IgM ELISA is the first line serological diagnostic test, which is then followed by confirmatory testing via detection of serum neutralizing antibodies against Nipah virus in the patient’s serum [<a href="#rid58">58</a>]. The use of neutralizing antibodies requires biosafety level 4 laboratory containment facilities; however, the use of neutralization assays based on noninfectious pseudotyped viruses bearing Nipah virus glycoproteins may be a way to avoid the need for live viruses [<a href="#rid15">15,59,60</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Treatment and prevention of Nipah virus infection</span><span class="headingEndMark"> — </span>Supportive care is the mainstay of treatment, and infected patients may require intensive care monitoring. Mechanical ventilation for airway protection should be initiated with the onset of neurologic deterioration. </p><p>No antiviral therapies have been proven to be effective for Nipah virus infection. There has been some interest in the nucleoside analogue <a class="drug drug_general" data-topicid="9860" href="/d/drug information/9860.html" rel="external">ribavirin</a>. Although ribavirin was found to be ineffective in animal models [<a href="#rid61">61,62</a>], small studies in humans suggest there may be some benefit. In one report, 140 patients treated with ribavirin during the Malaysian outbreak were compared with 54 patients who did not receive ribavirin, and fewer treated patients died (32 versus 54 percent) [<a href="#rid63">63</a>]. In a case series of 12 patients from Kerala, two of the six patients who received ribavirin survived, whereas the six untreated patients all had fatal outcomes, although this difference was not statistically significant [<a href="#rid21">21</a>]. Until more data are available, the role of ribavirin for the treatment of Nipah virus infection remains unclear.</p><p>Prevention efforts include educating at-risk populations about transmission of infection [<a href="#rid64">64</a>]. As examples: </p><p class="bulletIndent1"><span class="glyph">●</span>To reduce the risk of bat-to-human transmission, individuals should be advised to avoid raw palm sap that could be contaminated, although this can be difficult and requires sensitivity to local customs and beliefs [<a href="#rid65">65</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Individuals should wear gloves and other protective clothing while handling sick animals or their tissues and avoiding close unprotected physical contact with patients who have Nipah virus infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Health care workers who care for patients with suspected or confirmed infection, or handle their specimens, should implement standard infection control precautions, as well as contact and droplet precautions. (See  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection"</a>.)</p><p></p><p>Investigational approaches to preventing Nipah virus infection include vaccination and the use of monoclonal antibodies. A phase 1 dose-escalation study of an mRNA-1215 Nipah virus vaccine is underway to evaluate its safety, tolerability, and ability to generate an immune response in 40 healthy adults ages 18 to 60 years [<a href="#rid66">66</a>]. In a phase 1 clinical trial of the human monoclonal antibody (m102.4) no significant adverse side-effects were reported [<a href="#rid67">67</a>]. This agent was also administered as a compassionate-use therapy in 14 patients who had a high-risk henipavirus exposure, and none of the patients developed treatment-related adverse events or disease [<a href="#rid67">67-69</a>].</p><p class="headingAnchor" id="H15"><span class="h1">HENDRA VIRUS</span><span class="headingEndMark"> — </span>In September of 1994, an outbreak of acute, severe respiratory illness resulting in the death of 14 of 21 affected horses occurred in Queensland, Australia. Two humans, a trainer and a stable hand with close contact to these sick horses became ill and the trainer died [<a href="#rid16">16,17</a>]. The virus isolated from the horses' infected tissues was named Hendra after the Brisbane suburb where the outbreak occurred. Most of the equine cases have been reported in Queensland and Northern New South Wales. One equine case was reported in the Hunter Valley of New South Wales, but no human cases were reported [<a href="#rid70">70</a>].</p><p class="headingAnchor" id="H16"><span class="h2">Epidemiology of Hendra virus infection</span><span class="headingEndMark"> — </span>Hendra virus primarily infects horses. Human infection results from direct contact with infected horses. Animal–to-animal transmission has been demonstrated in dogs who had close contact with infected horses [<a href="#rid71">71,72</a>]. No human-to-human transmission has been documented [<a href="#rid73">73</a>].</p><p>Similar to Nipah virus, the natural host of Hendra virus is believed to be fruit bats of the <em>Pteropus</em> species, four of which have been demonstrated to have serologic evidence of infection with this virus [<a href="#rid74">74</a>]. The virus has also been isolated from fetal tissue and uterine fluids of these bats [<a href="#rid75">75</a>]. Although the virus appears to be widespread in the bat population, there is no clinical evidence of infection or seroconversion among bat caregivers, despite close contact with these mammals [<a href="#rid76">76</a>]. The mode of transmission of the virus from the natural hosts to the infected horses in the outbreak is unclear and the focus of reducing future henipavirus infections is to identify factors that will trigger a spillover infection from bats to livestock and humans [<a href="#rid77">77</a>].</p><p class="headingAnchor" id="H17"><span class="h2">Clinical features of Hendra virus infection</span><span class="headingEndMark"> — </span>Since Hendra virus was recognized, there have been about 100 infections in horses, and seven human infections with four fatalities [<a href="#rid77">77,78</a>]. The initial two patients had an acute influenza-like illness with fever and respiratory symptoms [<a href="#rid16">16</a>]. The third patient had a mild meningoencephalitis after nursing two ill horses that subsequently died [<a href="#rid18">18</a>]. After apparent full recovery, the farmer developed seizures, coma and died. Both the patient and the horses' tissues were seropositive for Hendra. MRI brain imaging showed focal high signal cortical lesions on T2 weighted sequences while the EEG showed persistent periodic epileptiform discharges [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H18"><span class="h2">Diagnosis of Hendra virus infection</span><span class="headingEndMark"> — </span>The diagnosis can be confirmed by ELISA or serum neutralization tests [<a href="#rid17">17</a>]. Specific, reliable polymerase chain reaction methods are also available [<a href="#rid79">79,80</a>].</p><p>Post mortem examination of one patient described above with respiratory illness showed severe interstitial pneumonia. In the fatal case with neurologic involvement, there were areas of focal necrosis with multinucleated endothelial cells. Viral antigen were demonstrated on immunohistochemistry [<a href="#rid16">16,18</a>].</p><p class="headingAnchor" id="H19"><span class="h2">Treatment and prevention of Hendra virus infection</span><span class="headingEndMark"> — </span>Supportive care is the mainstay of treatment and infected patients may require intensive care monitoring. Similar to Nipah virus, <a class="drug drug_general" data-topicid="9860" href="/d/drug information/9860.html" rel="external">ribavirin</a> has not been found to be effective in animal models of Hendra virus [<a href="#rid81">81</a>]. (See <a class="local">'Treatment and prevention of Nipah virus infection'</a> above.)</p><p>A vaccine based on the G glycoprotein of Hendra virus for horses has been approved for use in Australia [<a href="#rid82">82,83</a>]. Since its introduction in 2012, more than 120,000 horses have been vaccinated without any confirmed infections [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H985750495"><span class="h1">LANGYA HENIPAVIRUS</span><span class="headingEndMark"> — </span>A phylogenetically distinct henipavirus, named Langya henipavirus (LayV), was identified in China in 2019. One report identified 35 patients with acute LayV infection between 2019 to 2021 [<a href="#rid84">84</a>]. In this report, patients presented with fever, fatigue, cough, anorexia, myalgia, nausea, headache, and vomiting. Laboratory abnormalities included thrombocytopenia, leukopenia, and abnormal liver and kidney function. Infection was felt to occur through animal exposure; among wild animals, this virus was predominantly detected in shrews. There was no evidence of human-to-human transmission. </p><p class="headingAnchor" id="H190273294"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109959.html" rel="external">"Society guideline links: Infectious encephalitis"</a>.)</p><p class="headingAnchor" id="H20"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Virology</strong> – Nipah and Hendra viruses are two related zoonotic pathogens that have emerged in the Asia-Pacific region. Both are RNA viruses that belong to the Paramyxoviridae family. A phylogenetically distinct henipavirus, named Langya henipavirus (LayV), was identified in China in 2019. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nipah virus</strong> – Human infection from Nipah virus results from spillover transmission from bats or through human-to-human transmission. Transmission from bats can occur either through direct bat-to-human transmission or through indirect transmission from bats through an intermediate animal host (eg, pigs or horses). (See <a class="local">'Epidemiology of Nipah virus infection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Epidemiology of Hendra virus</strong> – Human infection with Hendra virus results from direct contact with infected horses. Patients have presented with fever and influenza-like illnesses or with meningoencephalitis. (See <a class="local">'Epidemiology of Hendra virus infection'</a> above and <a class="local">'Clinical features of Hendra virus infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – Nipah virus primarily causes an encephalitic syndrome with a high mortality rate. The characteristic MRI abnormalities are multiple, small (less than 5 mm), asymmetric focal lesions in the subcortical and deep white matter without surrounding edema. Respiratory symptoms and abnormal chest radiographs can also be seen. (See <a class="local">'Clinical features of Nipah virus infection'</a> above.)</p><p></p><p class="bulletIndent1">Patients with Hendra virus have presented with an acute influenza-like illness with fever and respiratory symptoms, as well as mild meningoencephalitis. Those with Langya henipavirus generally present with fever, fatigue, cough, anorexia, myalgia, nausea, headache, and vomiting. (See <a class="local">'Clinical features of Hendra virus infection'</a> above and <a class="local">'Langya henipavirus'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of Nipah and Hendra virus is generally established using methods such as polymerase chain reaction (PCR) testing or serologic testing using an enzyme-linked immunoassay (ELISA). (See <a class="local">'Diagnosis of Nipah virus infection'</a> above and <a class="local">'Diagnosis of Hendra virus infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment and prevention</strong> – For patients with henipavirus infection, supportive care is the mainstay of treatment; in addition, some patients may require intensive care monitoring.</p><p></p><p class="bulletIndent1">For Nipah virus, prevention efforts include educating at-risk populations about ways to reduce transmission of infection, mRNA vaccines and monoclonal antibodies are also being evaluated. An effective Hendra vaccine is available for horses. (See <a class="local">'Treatment and prevention of Nipah virus infection'</a> above and <a class="local">'Treatment and prevention of Hendra virus infection'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Chua KB, Bellini WJ, Rota PA, et al. Nipah virus: a recently emergent deadly paramyxovirus. Science 2000; 288:1432.</a></li><li><a class="nounderline abstract_t">Harcourt BH, Tamin A, Ksiazek TG, et al. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology 2000; 271:334.</a></li><li><a class="nounderline abstract_t">Wang LF, Yu M, Hansson E, et al. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol 2000; 74:9972.</a></li><li><a class="nounderline abstract_t">Wang L, Harcourt BH, Yu M, et al. Molecular biology of Hendra and Nipah viruses. Microbes Infect 2001; 3:279.</a></li><li><a class="nounderline abstract_t">Marsh GA, de Jong C, Barr JA, et al. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog 2012; 8:e1002836.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Update: outbreak of Nipah virus--Malaysia and Singapore, 1999. MMWR Morb Mortal Wkly Rep 1999; 48:335.</a></li><li><a class="nounderline abstract_t">Chua KB, Goh KJ, Wong KT, et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 1999; 354:1257.</a></li><li><a class="nounderline abstract_t">Paton NI, Leo YS, Zaki SR, et al. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet 1999; 354:1253.</a></li><li><a class="nounderline abstract_t">Goh KJ, Tan CT, Chew NK, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med 2000; 342:1229.</a></li><li><a class="nounderline abstract_t">Hsu VP, Hossain MJ, Parashar UD, et al. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 2004; 10:2082.</a></li><li><a class="nounderline abstract_t">Quddus R, Alam S, Majumdar MA, et al. A report of 4 patients with Nipah encephalitis from Rajbari district, Bangladesh in the January 2004 outbreak. Neurol Asia 2004; 9:33.</a></li><li><a class="nounderline abstract_t">Nipah virus outbreak(s) in Bangladesh, January-April 2004. Wkly Epidemiol Rec 2004; 79:168.</a></li><li><a class="nounderline abstract_t">Chadha MS, Comer JA, Lowe L, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 2006; 12:235.</a></li><li><a class="nounderline abstract_t">Arunkumar G, Chandni R, Mourya DT, et al. Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018. J Infect Dis 2019; 219:1867.</a></li><li><a class="nounderline abstract_t">Ching PK, de los Reyes VC, Sucaldito MN, et al. Outbreak of henipavirus infection, Philippines, 2014. Emerg Infect Dis 2015; 21:328.</a></li><li><a class="nounderline abstract_t">Selvey LA, Wells RM, McCormack JG, et al. Infection of humans and horses by a newly described morbillivirus. Med J Aust 1995; 162:642.</a></li><li><a class="nounderline abstract_t">Murray K, Selleck P, Hooper P, et al. A morbillivirus that caused fatal disease in horses and humans. Science 1995; 268:94.</a></li><li><a class="nounderline abstract_t">O'Sullivan JD, Allworth AM, Paterson DL, et al. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet 1997; 349:93.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Outbreak of Hendra-like virus--Malaysia and Singapore, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48:265.</a></li><li><a class="nounderline abstract_t">Hossain MJ, Gurley ES, Montgomery JM, et al. Clinical presentation of nipah virus infection in Bangladesh. Clin Infect Dis 2008; 46:977.</a></li><li><a class="nounderline abstract_t">Chandni R, Renjith TP, Fazal A, et al. Clinical Manifestations of Nipah Virus-Infected Patients Who Presented to the Emergency Department During an Outbreak in Kerala State in India, May 2018. Clin Infect Dis 2020; 71:152.</a></li><li><a class="nounderline abstract_t">Yob JM, Field H, Rashdi AM, et al. Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerg Infect Dis 2001; 7:439.</a></li><li><a class="nounderline abstract_t">Mackenzie JS, Chua KB, Daniels PW, et al. Emerging viral diseases of Southeast Asia and the Western Pacific. Emerg Infect Dis 2001; 7:497.</a></li><li><a class="nounderline abstract_t">Halpin K, Hyatt AD, Plowright RK, et al. Emerging viruses: coming in on a wrinkled wing and a prayer. Clin Infect Dis 2007; 44:711.</a></li><li><a class="nounderline abstract_t">Field HE, Mackenzie JS, Daszak P. Henipaviruses: emerging paramyxoviruses associated with fruit bats. Curr Top Microbiol Immunol 2007; 315:133.</a></li><li><a class="nounderline abstract_t">Chua KB, Koh CL, Hooi PS, et al. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect 2002; 4:145.</a></li><li><a class="nounderline abstract_t">Chong HT, Abdullah S, Tan CT. Nipah virus and bats. Neurology Asia 2009; 14:73.</a></li><li><a class="nounderline abstract_t">Yadav PD, Shete AM, Kumar GA, et al. Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018. Emerg Infect Dis 2019; 25:1003.</a></li><li><a class="nounderline abstract_t">de Araujo J, Lo MK, Tamin A, et al. Antibodies Against Henipa-Like Viruses in Brazilian Bats. Vector Borne Zoonotic Dis 2017; 17:271.</a></li><li><a class="nounderline abstract_t">Sabchareon A, Yoksan S. Japanese encephalitis. Ann Trop Paediatr 1998; 18 Suppl:S67.</a></li><li><a class="nounderline abstract_t">Mohd Nor MN, Gan CH, Ong BL. Nipah virus infection of pigs in peninsular Malaysia. Rev Sci Tech 2000; 19:160.</a></li><li><a class="nounderline abstract_t">Cortes MC, Cauchemez S, Lefrancq N, et al. Characterization of the Spatial and Temporal Distribution of Nipah Virus Spillover Events in Bangladesh, 2007-2013. J Infect Dis 2018; 217:1390.</a></li><li><a class="nounderline abstract_t">Harcourt BH, Lowe L, Tamin A, et al. Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis 2005; 11:1594.</a></li><li><a class="nounderline abstract_t">Lo MK, Lowe L, Hummel KB, et al. Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010. Emerg Infect Dis 2012; 18:248.</a></li><li><a class="nounderline abstract_t">Clayton BA. Nipah virus: transmission of a zoonotic paramyxovirus. Curr Opin Virol 2017; 22:97.</a></li><li><a class="nounderline abstract_t">Nikolay B, Salje H, Hossain MJ, et al. Transmission of Nipah Virus - 14 Years of Investigations in Bangladesh. N Engl J Med 2019; 380:1804.</a></li><li><a class="nounderline abstract_t">Parashar UD, Sunn LM, Ong F, et al. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis 2000; 181:1755.</a></li><li><a class="nounderline abstract_t">Chew MH, Arguin PM, Shay DK, et al. Risk factors for Nipah virus infection among abattoir workers in Singapore. J Infect Dis 2000; 181:1760.</a></li><li><a class="nounderline abstract_t">Sahani M, Parashar UD, Ali R, et al. Nipah virus infection among abattoir workers in Malaysia, 1998-1999. Int J Epidemiol 2001; 30:1017.</a></li><li><a class="nounderline abstract_t">Ali R, Mounts AW, Parashar UD, et al. Nipah virus among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998-1999. Emerg Infect Dis 2001; 7:759.</a></li><li><a class="nounderline abstract_t">Tan KS, Tan CT, Goh KJ. Epidemiological aspects of Nipah virus infection. Neurol J Southeast Asia 1999; 4:77.</a></li><li><a class="nounderline abstract_t">Luby SP, Hossain MJ, Gurley ES, et al. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis 2009; 15:1229.</a></li><li><a class="nounderline abstract_t">Luby SP. The pandemic potential of Nipah virus. Antiviral Res 2013; 100:38.</a></li><li><a class="nounderline abstract_t">Montgomery JM, Hossain MJ, Gurley E, et al. Risk factors for Nipah virus encephalitis in Bangladesh. Emerg Infect Dis 2008; 14:1526.</a></li><li><a class="nounderline abstract_t">Luby SP, Rahman M, Hossain MJ, et al. Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis 2006; 12:1888.</a></li><li><a class="nounderline abstract_t">Gurley ES, Montgomery JM, Hossain MJ, et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 2007; 13:1031.</a></li><li><a class="nounderline abstract_t">Sazzad HM, Hossain MJ, Gurley ES, et al. Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh. Emerg Infect Dis 2013; 19:210.</a></li><li class="breakAll">World Health Organization. Nipah virus infection - Bangladesh. https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON442 (Accessed on February 21, 2023).</li><li><a class="nounderline abstract_t">Sudeep AB, Yadav PD, Gokhale MD, et al. Detection of Nipah virus in Pteropus medius in 2019 outbreak from Ernakulam district, Kerala, India. BMC Infect Dis 2021; 21:162.</a></li><li><a class="nounderline abstract_t">Yadav PD, Sahay RR, Balakrishnan A, et al. Nipah Virus Outbreak in Kerala State, India Amidst of COVID-19 Pandemic. Front Public Health 2022; 10:818545.</a></li><li><a class="nounderline abstract_t">Wong KT, Shieh WJ, Kumar S, et al. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 2002; 161:2153.</a></li><li><a class="nounderline abstract_t">Tan CT, Goh KJ, Wong KT, et al. Relapsed and late-onset Nipah encephalitis. Ann Neurol 2002; 51:703.</a></li><li><a class="nounderline abstract_t">Nipah virus control needs more than R&amp;D. Lancet 2018; 391:2295.</a></li><li><a class="nounderline abstract_t">Sarji SA, Abdullah BJ, Goh KJ, et al. MR imaging features of Nipah encephalitis. AJR Am J Roentgenol 2000; 175:437.</a></li><li><a class="nounderline abstract_t">Sejvar JJ, Hossain J, Saha SK, et al. Long-term neurological and functional outcome in Nipah virus infection. Ann Neurol 2007; 62:235.</a></li><li><a class="nounderline abstract_t">Siva SR, Chong HT, Tan CT. Ten-year clinical and serological outcomes of Nipah virus infection. Neurol Asia 2009; 14:53.</a></li><li><a class="nounderline abstract_t">Lim CC, Sitoh YY, Lee KE, et al. Meningoencephalitis caused by a novel paramyxovirus: an advanced MRI case report in an emerging disease. Singapore Med J 1999; 40:356.</a></li><li><a class="nounderline abstract_t">Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect 2001; 3:289.</a></li><li><a class="nounderline abstract_t">Tamin A, Harcourt BH, Lo MK, et al. Development of a neutralization assay for Nipah virus using pseudotype particles. J Virol Methods 2009; 160:1.</a></li><li><a class="nounderline abstract_t">Kaku Y, Noguchi A, Marsh GA, et al. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase. J Virol Methods 2012; 179:226.</a></li><li><a class="nounderline abstract_t">Freiberg AN, Worthy MN, Lee B, Holbrook MR. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection. J Gen Virol 2010; 91:765.</a></li><li><a class="nounderline abstract_t">Pallister J, Middleton D, Crameri G, et al. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets. J Virol 2009; 83:11979.</a></li><li><a class="nounderline abstract_t">Chong HT, Kamarulzaman A, Tan CT, et al. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol 2001; 49:810.</a></li><li class="breakAll">World Health Organization.Nipah virus. http://www.who.int/news-room/fact-sheets/detail/nipah-virus (Accessed on June 13, 2018).</li><li><a class="nounderline abstract_t">Parveen S, Islam MS, Begum M, et al. It's not only what you say, it's also how you say it: communicating nipah virus prevention messages during an outbreak in Bangladesh. BMC Public Health 2016; 16:726.</a></li><li class="breakAll">National Institutes of Health. NIH launches clinical trial of mRNA Nipah virus vaccine. https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trial-mrna-nipah-virus-vaccine (Accessed on September 27, 2022).</li><li><a class="nounderline abstract_t">Playford EG, Munro T, Mahler SM, et al. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. Lancet Infect Dis 2020; 20:445.</a></li><li><a class="nounderline abstract_t">Broder CC, Weir DL, Reid PA. Hendra virus and Nipah virus animal vaccines. Vaccine 2016; 34:3525.</a></li><li><a class="nounderline abstract_t">Johnson K, Vu M, Freiberg AN. Recent advances in combating Nipah virus. Fac Rev 2021; 10:74.</a></li><li><a class="nounderline abstract_t">Williamson KM, Wheeler S, Kerr J, et al. Hendra in the Hunter Valley. One Health 2020; 10:100162.</a></li><li><a class="nounderline abstract_t">Kirkland PD, Gabor M, Poe I, et al. Hendra Virus Infection in Dog, Australia, 2013. Emerg Infect Dis 2015; 21:2182.</a></li><li><a class="nounderline abstract_t">Halim S, Polkinghorne B, Bell G, et al. Outbreak-related Hendra virus infection in a NSW pet dog. Public Health Res Pract 2015; 25:e2541547.</a></li><li><a class="nounderline abstract_t">Playford EG, McCall B, Smith G, et al. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis 2010; 16:219.</a></li><li><a class="nounderline abstract_t">Young PL, Halpin K, Selleck PW, et al. Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis 1996; 2:239.</a></li><li><a class="nounderline abstract_t">Halpin K, Young PL, Field HE, Mackenzie JS. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol 2000; 81:1927.</a></li><li><a class="nounderline abstract_t">Selvey L, Taylor R, Arklay A, Gerrard J. Screening of bat carers for antibodies to equine morbillivirus. Com Dis Intell 1996; 20:477.</a></li><li><a class="nounderline abstract_t">Field, H. Hendra virus infection risks. Neurol Asia 2009; 14:77.</a></li><li><a class="nounderline abstract_t">Field HE. Hendra virus ecology and transmission. Curr Opin Virol 2016; 16:120.</a></li><li><a class="nounderline abstract_t">Ong KC, Wong KT. Henipavirus Encephalitis: Recent Developments and Advances. Brain Pathol 2015; 25:605.</a></li><li><a class="nounderline abstract_t">Middleton D. Hendra virus. Vet Clin North Am Equine Pract 2014; 30:579.</a></li><li><a class="nounderline abstract_t">Rockx B, Bossart KN, Feldmann F, et al. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol 2010; 84:9831.</a></li><li><a class="nounderline abstract_t">Broder CC, Xu K, Nikolov DB, et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res 2013; 100:8.</a></li><li><a class="nounderline abstract_t">Balzer M. Hendra vaccine success announced. Aust Vet J 2011; 89:N2.</a></li><li><a class="nounderline abstract_t">Zhang XA, Li H, Jiang FC, et al. A Zoonotic Henipavirus in Febrile Patients in China. N Engl J Med 2022; 387:470.</a></li></ol></div><div id="topicVersionRevision">Topic 1295 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10827955" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Nipah virus: a recently emergent deadly paramyxovirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10860887" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Molecular characterization of Nipah virus, a newly emergent paramyxovirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11024125" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11334745" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Molecular biology of Hendra and Nipah viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22879820" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Cedar virus: a novel Henipavirus isolated from Australian bats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10366143" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Update: outbreak of Nipah virus--Malaysia and Singapore, 1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10520635" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10520634" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Outbreak of Nipah-virus infection among abattoir workers in Singapore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10781618" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical features of Nipah virus encephalitis among pig farmers in Malaysia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15663842" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Nipah virus encephalitis reemergence, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : A report of 4 patients with Nipah encephalitis from Rajbari district, Bangladesh in the January 2004 outbreak</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15132054" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Nipah virus outbreak(s) in Bangladesh, January-April 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16494748" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Nipah virus-associated encephalitis outbreak, Siliguri, India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30364984" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25626011" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Outbreak of henipavirus infection, Philippines, 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7603375" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Infection of humans and horses by a newly described morbillivirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7701348" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A morbillivirus that caused fatal disease in horses and humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8996421" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Fatal encephalitis due to novel paramyxovirus transmitted from horses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10227800" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Outbreak of Hendra-like virus--Malaysia and Singapore, 1998-1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18444812" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Clinical presentation of nipah virus infection in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31627214" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Clinical Manifestations of Nipah Virus-Infected Patients Who Presented to the Emergency Department During an Outbreak in Kerala State in India, May 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11384522" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11485641" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Emerging viral diseases of Southeast Asia and the Western Pacific.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17278066" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Emerging viruses: coming in on a wrinkled wing and a prayer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17848064" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Henipaviruses: emerging paramyxoviruses associated with fruit bats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11880045" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Isolation of Nipah virus from Malaysian Island flying-foxes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Nipah virus and bats</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31002049" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Nipah Virus Sequences from Humans and Bats during Nipah Outbreak, Kerala, India, 2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28103156" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Antibodies Against Henipa-Like Viruses in Brazilian Bats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9876271" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Japanese encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11189713" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Nipah virus infection of pigs in peninsular Malaysia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29351657" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Characterization of the Spatial and Temporal Distribution of Nipah Virus Spillover Events in Bangladesh, 2007-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16318702" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Genetic characterization of Nipah virus, Bangladesh, 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22304936" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28088124" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Nipah virus: transmission of a zoonotic paramyxovirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31067370" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Transmission of Nipah Virus - 14 Years of Investigations in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10823779" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10823780" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Risk factors for Nipah virus infection among abattoir workers in Singapore.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11689513" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Nipah virus infection among abattoir workers in Malaysia, 1998-1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11592256" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Nipah virus among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998-1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Epidemiological aspects of Nipah virus infection</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19751584" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23911335" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : The pandemic potential of Nipah virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18826814" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Risk factors for Nipah virus encephalitis in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17326940" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Foodborne transmission of Nipah virus, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18214175" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Person-to-person transmission of Nipah virus in a Bangladeshi community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23347678" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23347678" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Nipah virus infection outbreak with nosocomial and corpse-to-human transmission, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33563231" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Detection of Nipah virus in Pteropus medius in 2019 outbreak from Ernakulam district, Kerala, India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35252095" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Nipah Virus Outbreak in Kerala State, India Amidst of COVID-19 Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12466131" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12112075" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Relapsed and late-onset Nipah encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Nipah virus control needs more than R&amp;D</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10915690" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : MR imaging features of Nipah encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17696217" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Long-term neurological and functional outcome in Nipah virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Ten-year clinical and serological outcomes of Nipah virus infection</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10489496" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Meningoencephalitis caused by a novel paramyxovirus: an advanced MRI case report in an emerging disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11334746" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Laboratory diagnosis of Nipah and Hendra virus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19559943" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Development of a neutralization assay for Nipah virus using pseudotype particles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22115786" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19889926" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19759137" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11409437" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Treatment of acute Nipah encephalitis with ribavirin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11409437" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Treatment of acute Nipah encephalitis with ribavirin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27495927" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : It's not only what you say, it's also how you say it: communicating nipah virus prevention messages during an outbreak in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27495927" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : It's not only what you say, it's also how you say it: communicating nipah virus prevention messages during an outbreak in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32027842" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27154393" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Hendra virus and Nipah virus animal vaccines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34632460" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Recent advances in combating Nipah virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33117876" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Hendra in the Hunter Valley.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26583697" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Hendra Virus Infection in Dog, Australia, 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26536509" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Outbreak-related Hendra virus infection in a NSW pet dog.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20113550" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8903239" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10900029" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Screening of bat carers for antibodies to equine morbillivirus</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Hendra virus infection risks</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26978066" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Hendra virus ecology and transmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26276024" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Henipavirus Encephalitis: Recent Developments and Advances.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25281398" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Hendra virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20660198" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23838047" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : A treatment for and vaccine against the deadly Hendra and Nipah viruses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21834199" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Hendra vaccine success announced.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35921459" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : A Zoonotic Henipavirus in Febrile Patients in China.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
